These results not only underscore the critical role of PLCβ-dependent S-eCB mobilization in hippocampal synaptic plasticity and memory in the healthy brains, but also suggest that PLCβ1 could serve as a therapeutic target for improving hippocampal synaptic plasticity and memory-impaired by amyloidosis in AD. This evidence concerns the gene PLCB1 and Alzheimer disease.